Synthetic lethality-based predictive biomarker identification of splicing modulators in lung cancer

被引：0
|
作者：
Repellin, Claire E. [1 ]
Patel, Puja [1 ]
Shi, Yihui [1 ]
Gong, Helena [1 ]
Webb, Thomas R. [1 ]
Sambucetti, Lidia [1 ]
Sinha, Subarna [1 ]
机构：
[1] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4015
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Synthetic lethality in lung cancer and translation to clinical therapies
    Ada W. Y. Leung
    Tanya de Silva
    Marcel B. Bally
    William W. Lockwood
    Molecular Cancer, 15
  • [12] Synthetic lethality in lung cancer and translation to clinical therapies
    Leung, Ada W. Y.
    de Silva, Tanya
    Bally, Marcel B.
    Lockwood, William W.
    MOLECULAR CANCER, 2016, 15
  • [13] A Synthetic Lethality-Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1
    Oike, Takahiro
    Ogiwara, Hideaki
    Tominaga, Yuichi
    Ito, Kentaro
    Ando, Osamu
    Tsuta, Koji
    Mizukami, Tatsuji
    Shimada, Yoko
    Isomura, Hisanori
    Komachi, Mayumi
    Furuta, Koh
    Watanabe, Shun-Ichi
    Nakano, Takashi
    Yokota, Jun
    Kohno, Takashi
    CANCER RESEARCH, 2013, 73 (17) : 5508 - 5518
  • [14] Patient-derived tissue slice grafts of high-risk primary prostate cancer: An authentic preclinical model for synthetic lethality-based therapy
    Zhao, Hongjuan
    Thong, Alan
    Nolley, Rosie
    Reese, Stephen
    Santos, Jennifer
    Ingels, Alexandre
    Peehl, Donna
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)
  • [15] Angiogenesis in lung cancer: predictive plasma biomarker profiles
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S21 - S22
  • [16] Predictive and prognostic biomarker models in advanced lung cancer
    Holdenrieder, S.
    Nagel, D.
    Heinemann, V.
    von Pawel, J.
    Raith, H.
    Feldmann, K.
    Stenman, U.
    Stieber, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [17] Immunocytochemistry for predictive biomarker testing in lung cancer cytology
    Jain, Deepali
    Nambirajan, Aruna
    Borczuk, Alain
    Chen, Gang
    Minami, Yuko
    Moreira, Andre L.
    Motoi, Noriko
    Papotti, Mauro
    Rekhtman, Natasha
    Russell, Prudence A.
    Prince, Spasenija Savic
    Yatabe, Yasushi
    Bubendorf, Lukas
    CANCER CYTOPATHOLOGY, 2019, 127 (05) : 325 - 339
  • [18] A Synthetic Lethality-Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1-Letter
    Thompson, Kenneth W.
    Marquez, Stefanie B.
    Reisman, David
    CANCER RESEARCH, 2014, 74 (17) : 4946 - 4947
  • [19] Synthetic Lethality-Based Approach Identified EED and BRD4 As Critical Survival Factorsin Acte Myeloid Leukemia with Monosomy 7
    Matsuda, Kensuke
    Kagoya, Yuki
    Yamazaki, Sho
    Miyauchi, Masashi
    Kurokawa, Mineo
    BLOOD, 2019, 134
  • [20] Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection
    El-Khoury, Victoria
    Schritz, Anna
    Kim, Sang-Yoon
    Lesur, Antoine
    Sertamo, Katriina
    Bernardin, Francois
    Petritis, Konstantinos
    Pirrotte, Patrick
    Selinsky, Cheryl
    Whiteaker, Jeffrey R.
    Zhang, Haizhen
    Kennedy, Jacob J.
    Lin, Chenwei
    Lee, Lik Wee
    Yan, Ping
    Tran, Nhan L.
    Inge, Landon J.
    Chalabi, Khaled
    Decker, Georges
    Bjerkvig, Rolf
    Paulovich, Amanda G.
    Berchem, Guy
    Kim, Yeoun Jin
    CANCERS, 2020, 12 (06) : 1 - 15
12345